CST castile resources ltd

quantiferon-tb gold lodged for regulatory approval

  1. 4,086 Posts.
    FYI


    6 JUNE 2003
    ASX ANNOUNCEMENT – CELLESTIS LIMITED (CST)
    QUANTIFERON-TB GOLD LODGED FOR REGULATORY APPROVAL IN
    JAPAN
    Nichirei Corporation of Japan, the distributor of QuantiFERON in Japan, have
    advised Cellestis that they have lodged an application with the Ministry of
    Health, Labour and Welfare for QuantiFERON-TB GOLD (registered as
    QuantiFERON-TB2G) to be approved for sale as a tuberculosis diagnostic in
    Japan.
    Neither Nichirei nor Cellestis can offer any warranty as to how quickly
    approval may take, and approval is not guaranteed, but it is unlikely to occur
    within the calendar year 2003.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.2¢
Change
0.007(12.7%)
Mkt cap ! $18.95M
Open High Low Value Volume
5.5¢ 6.2¢ 5.5¢ $42.1K 715.1K

Buyers (Bids)

No. Vol. Price($)
1 22197 5.4¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 74751 1
View Market Depth
Last trade - 14.46pm 20/06/2025 (20 minute delay) ?
CST (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.